305 related articles for article (PubMed ID: 22016411)
21. Intraoperative Magnetic Resonance Imaging for Low-Grade and High-Grade Gliomas: What Is the Evidence? A Meta-Analysis.
Lo YT; Lee H; Shui C; Lamba N; Korde R; Devi S; Chawla S; Nam Y; Patel R; Doucette J; Bunevicius A; Mekary RA
World Neurosurg; 2021 May; 149():232-243.e3. PubMed ID: 33540099
[TBL] [Abstract][Full Text] [Related]
22. Advanced MR imaging techniques in the diagnosis of intraaxial brain tumors in adults.
Al-Okaili RN; Krejza J; Wang S; Woo JH; Melhem ER
Radiographics; 2006 Oct; 26 Suppl 1():S173-89. PubMed ID: 17050514
[TBL] [Abstract][Full Text] [Related]
23. Clinical applications of proton MR spectroscopy in oncology.
Kwock L; Smith JK; Castillo M; Ewend MG; Cush S; Hensing T; Varia M; Morris D; Bouldin TW
Technol Cancer Res Treat; 2002 Feb; 1(1):17-28. PubMed ID: 12614173
[TBL] [Abstract][Full Text] [Related]
24. Advanced MR imaging in hemispheric low-grade gliomas before surgery; the indications and limits in the pediatric age.
Gaudino S; Russo R; Verdolotti T; Caulo M; Colosimo C
Childs Nerv Syst; 2016 Oct; 32(10):1813-22. PubMed ID: 27659824
[TBL] [Abstract][Full Text] [Related]
25. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging.
Kim DS; Na DG; Kim KH; Kim JH; Kim E; Yun BL; Chang KH
Radiology; 2009 May; 251(2):467-75. PubMed ID: 19261924
[TBL] [Abstract][Full Text] [Related]
26. Assessment of functional MR imaging in neurosurgical planning.
Lee CC; Ward HA; Sharbrough FW; Meyer FB; Marsh WR; Raffel C; So EL; Cascino GD; Shin C; Xu Y; Riederer SJ; Jack CR
AJNR Am J Neuroradiol; 1999 Sep; 20(8):1511-9. PubMed ID: 10512239
[TBL] [Abstract][Full Text] [Related]
27. Optimizing brain tumor resection. Midfield interventional MR imaging.
Alexander E
Neuroimaging Clin N Am; 2001 Nov; 11(4):659-72. PubMed ID: 11995421
[TBL] [Abstract][Full Text] [Related]
28. [Towards more precision in the therapy of brain tumors. Possibilities and limits of MRI].
Radbruch A; Hattingen E
Nervenarzt; 2015 Jun; 86(6):701-2, 704-9. PubMed ID: 26017379
[TBL] [Abstract][Full Text] [Related]
29. Central nervous system lymphoma: characteristic findings on traditional and advanced imaging.
Haldorsen IS; Espeland A; Larsson EM
AJNR Am J Neuroradiol; 2011; 32(6):984-92. PubMed ID: 20616176
[TBL] [Abstract][Full Text] [Related]
30. Morphological and functional MRI, MRS, perfusion and diffusion changes after radiosurgery of brain metastasis.
Kang TW; Kim ST; Byun HS; Jeon P; Kim K; Kim H; Lee JI
Eur J Radiol; 2009 Dec; 72(3):370-80. PubMed ID: 18829196
[TBL] [Abstract][Full Text] [Related]
31. [Contrast-enhanced MR "magnetization transfer technique". Improved tumor contrast, delineation and visibility of intracranial malignant gliomas and metastases in radiosurgical treatment planning].
Hawighorst H; Schreiber W; Debus J; Knopp MV; Engenhart-Cabillic R; Brix G; Essig M; van Kaick G
Strahlenther Onkol; 1997 Dec; 173(12):684-92. PubMed ID: 9454354
[TBL] [Abstract][Full Text] [Related]
32. Advanced MR Imaging in Pediatric Brain Tumors, Clinical Applications.
Lequin M; Hendrikse J
Neuroimaging Clin N Am; 2017 Feb; 27(1):167-190. PubMed ID: 27889022
[TBL] [Abstract][Full Text] [Related]
33. New applications of MR contrast agents in neuroradiology.
Sze G
Neuroradiology; 1990; 32(5):421-38. PubMed ID: 2259437
[TBL] [Abstract][Full Text] [Related]
34. Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy.
Floeth FW; Pauleit D; Wittsack HJ; Langen KJ; Reifenberger G; Hamacher K; Messing-Jünger M; Zilles K; Weber F; Stummer W; Steiger HJ; Woebker G; Müller HW; Coenen H; Sabel M
J Neurosurg; 2005 Feb; 102(2):318-27. PubMed ID: 15739561
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in imaging of brain tumors.
Sanghvi DA
Indian J Cancer; 2009; 46(2):82-7. PubMed ID: 19346641
[TBL] [Abstract][Full Text] [Related]
36. Preliminary experience with MR-guided thermal ablation of brain tumors.
Anzai Y; Lufkin R; DeSalles A; Hamilton DR; Farahani K; Black KL
AJNR Am J Neuroradiol; 1995 Jan; 16(1):39-48; discussion 49-52. PubMed ID: 7900601
[TBL] [Abstract][Full Text] [Related]
37. Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery.
Graves EE; Nelson SJ; Vigneron DB; Verhey L; McDermott M; Larson D; Chang S; Prados MD; Dillon WP
AJNR Am J Neuroradiol; 2001 Apr; 22(4):613-24. PubMed ID: 11290467
[TBL] [Abstract][Full Text] [Related]
38. The EPTN consensus-based atlas for CT- and MR-based contouring in neuro-oncology.
Eekers DB; In 't Ven L; Roelofs E; Postma A; Alapetite C; Burnet NG; Calugaru V; Compter I; Coremans IEM; Høyer M; Lambrecht M; Nyström PW; Méndez Romero A; Paulsen F; Perpar A; de Ruysscher D; Renard L; Timmermann B; Vitek P; Weber DC; van der Weide HL; Whitfield GA; Wiggenraad R; Troost EGC;
Radiother Oncol; 2018 Jul; 128(1):37-43. PubMed ID: 29548560
[TBL] [Abstract][Full Text] [Related]
39. Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging.
Fink JR; Muzi M; Peck M; Krohn KA
J Nucl Med; 2015 Oct; 56(10):1554-61. PubMed ID: 26294301
[TBL] [Abstract][Full Text] [Related]
40. Management of breast lesions detectable only on MRI.
Siegmann-Luz KC; Bahrs SD; Preibsch H; Hattermann V; Claussen CD
Rofo; 2014 Jan; 186(1):30-6. PubMed ID: 23897532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
